Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT06968429

Efficacy and Safety of Oral NBP Soft Capsules for the Prevention of Episode Migraine Attacks in Adult Migraine Patients

Efficacy and Safety of Oral NBP Soft Capsules for the Prevention of Episode Migraine Attacks in Adult Migraine Patients: a Multi-center, Randomized, Double-blind, Placebo-controlled Trial

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
500 (estimated)
Sponsor
Chinese PLA General Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This is a multicentre, randomised, double-blind, placebo-controlled study to evaluate the efficacy, safety and tolerability of oral butylphthalide soft capsules for the prophylactic treatment of migraine in adults.

Conditions

Interventions

TypeNameDescription
DRUGNBP Softgel Capsulestake orally on an empty stomach;2 capsules 3/day
DRUGPlacebotake orally on an empty stomach;2 capsules 3/day

Timeline

Start date
2025-05-01
Primary completion
2027-12-01
Completion
2028-12-01
First posted
2025-05-13
Last updated
2025-05-13

Source: ClinicalTrials.gov record NCT06968429. Inclusion in this directory is not an endorsement.

Efficacy and Safety of Oral NBP Soft Capsules for the Prevention of Episode Migraine Attacks in Adult Migraine Patients (NCT06968429) · Clinical Trials Directory